Clinical Trials Directory

Trials / Completed

CompletedNCT05705596

Impact of Hesperetin in Combination With Sucrose on Energy Metabolism

Einfluss Des süßmodulierenden Polyphenols Hesperetin in Kombination Mit Saccharose Auf Die Blutglukose-Regulierung Und Energieaufnahme in Abhängigkeit Der Süßwahrnehmung

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
33 (actual)
Sponsor
University of Vienna · Academic / Other
Sex
Male
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The aim of this cross-over intervention study is to investigate the influence of the sweet-modulating substance hesperetin in combination with sucrose in comparison to an equally sweet-tasting sucrose-only solution on markers of energy metabolism.

Detailed description

The study is designed as a randomised cross-over intervention study with two arms. The aim is to investigate the influence of a 10% sucrose solution, corresponding to the sugar content of a conventional soft drink, compared to an equally sweet-tasting 7% sucrose solution in combination with 50 mg/L of the polyphenol hesperetin, on time-dependent blood glucose fluctuations and ad libitum energy intake in metabolically healthy male volunteers. To investigate the underlying mechanisms, the individual appetite score, metabolic and hormonal responses to the interventions and circulating extracellular vesicles and their miRNA composition will be measured. In addition, the participants' individual thresholds for sweet taste, preference and consumption for sweet-tasting foods such as sugar and sweeteners, and their body composition will be recorded as potential influencing factors.

Conditions

Interventions

TypeNameDescription
OTHERSucrose10% sucrose corresponding to a regular soft drink
DRUGHesperetinincreases sweetness of 7% sucrose solution to match sweetness of 10% sucrose solution

Timeline

Start date
2023-01-31
Primary completion
2023-06-30
Completion
2023-11-15
First posted
2023-01-31
Last updated
2023-11-28

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT05705596. Inclusion in this directory is not an endorsement.